CSIMarket Company Name, Ticker, Competitors, else..
 
Albireo Pharma inc   (NASDAQ: ALBO)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 20
 Employees -
 Revenues (TTM) (Millions $) 57
 Net Income (TTM) (Millions $) -131
 Cash Flow (TTM) (Millions $) 10
 Capital Exp. (TTM) (Millions $) 1

Business Description


Albireo Pharma Inc is a biopharmaceutical company that specializes in the development and commercialization of therapies for rare pediatric liver diseases. The company's focus is on advancing treatments for conditions such as progressive familial intrahepatic cholestasis (PFIC) and biliary atresia. Albireo Pharma's lead product candidate is odevixibat, which is currently in clinical trials and has shown promising results in treating cholestatic liver diseases. The company is dedicated to addressing the unmet medical needs of patients and providing innovative solutions in the field of pediatric liver diseases.


   Company Address: 53 State Street Boston 2109 MA
   Company Phone Number: 254-5555   Stock Exchange / Ticker: NASDAQ ALBO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 5.88
Working Capital Ratio 6.32
Leverage Ratio (MRQ) 2.21
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -6.72 $
Revenues (TTM) 2.92 $
Cash Flow (TTM) 0.5 $
Cash 11.32 $
Book Value 5.09 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) 27.25
Inventory Turnover Ratio (TTM) 1.4
Asset Turnover Ratio (TTM) 0.21

Profitability Ratios Current
Gross Margin (MRQ) 93.78 %
Operating Margin (MRQ) -352.49 %
Net Margin (MRQ) -384.46 %
Net Cash Flow Margin (MRQ) 930.69 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.